Trial Profile
The Effect of a Dexmedetomidine-focussed Sleep Protocol* on Delirium Incidence and Healthcare Costs in Critically Ill Patients: A Prospective Randomized, Double-blind, Pilot Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Mar 2018
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Delirium
- Focus Therapeutic Use
- Acronyms SKY-DEX
- 02 Mar 2018 Primary endpoint (Development of delirium) has been met, according to the results published in the American Journal of Respiratory and Critical Care Medicine
- 02 Mar 2018 Results published in the American Journal of Respiratory and Critical Care Medicine
- 15 Mar 2017 Status changed from recruiting to completed.